Revised Medical Criteria for Evaluating Human Immunodeficiency Virus (HIV) Infection and for Evaluating Functional Limitations in Immune System Disorders; Correction and Extension of Comment Period, 16250 [2014-06524]

Download as PDF 16250 Federal Register / Vol. 79, No. 57 / Tuesday, March 25, 2014 / Proposed Rules (g) Other FAA AD Provisions The following provisions also apply to this AD: (1) Alternative Methods of Compliance (AMOCs): The Manager, Standards Office, FAA, has the authority to approve AMOCs for this AD, if requested using the procedures found in 14 CFR 39.19. Send information to ATTN: Jim Rutherford, Aerospace Engineer, FAA, Small Airplane Directorate, 901 Locust, Room 301, Kansas City, Missouri 64106; telephone: (816) 329–4165; fax: (816) 329– 4090; email: jim.rutherford@faa.gov. Before using any approved AMOC on any airplane to which the AMOC applies, notify your appropriate principal inspector (PI) in the FAA Flight Standards District Office (FSDO), or lacking a PI, your local FSDO. (2) Airworthy Product: For any requirement in this AD to obtain corrective actions from a manufacturer or other source, use these actions if they are FAA-approved. Corrective actions are considered FAA-approved if they are approved by the State of Design Authority (or their delegated agent). You are required to assure the product is airworthy before it is returned to service. (h) Related Information Refer to MCAI European Aviation Safety Agency (EASA) AD No.: 2014–0015, dated January 14, 2014, for related information. You may examine the MCAI on the Internet at http://www.regulations.gov by searching for and locating Docket No. FAA–2014–0180. For service information related to this AD, contact Allstar PZL Glider, Sp. z o. o., ul. Cieszynska 325, 43–300 Bielsko-Biala, Poland; telephone: +48 33 812 50 26; fax: +48 33 812 3739; email: techsupport@szd.com.pl; Internet: http://szd.com.pl/en/products/szd50-3-puchacz. You may review copies of the referenced service information at the FAA, Small Airplane Directorate, 901 Locust, Kansas City, Missouri 64106. For information on the availability of this material at the FAA, call (816) 329–4148. Issued in Kansas City, Missouri, on March 19, 2014. James E. Jackson, Acting Manager, Small Airplane Directorate, Aircraft Certification Service. [FR Doc. 2014–06497 Filed 3–24–14; 8:45 am] BILLING CODE 4910–13–P SOCIAL SECURITY ADMINISTRATION 20 CFR Part 404 [Docket No. SSA–2007–0082] tkelley on DSK3SPTVN1PROD with PROPOSALS RIN 0960–AG71 Revised Medical Criteria for Evaluating Human Immunodeficiency Virus (HIV) Infection and for Evaluating Functional Limitations in Immune System Disorders; Correction and Extension of Comment Period Social Security Administration. Proposed rule; correction and extension of comment period. AGENCY: ACTION: VerDate Mar<15>2010 18:31 Mar 24, 2014 Jkt 232001 This document corrects and extends the deadline for submitting comments on the notice of proposed rulemaking (NPRM) published in the Federal Register on Wednesday, February 26, 2014, regarding Revised Medical Criteria for Evaluating Human Immunodeficiency Virus (HIV) Infection and for Evaluating Functional Limitations in Immune System Disorders. DATES: The comment period for the proposed rule, published February 26, 2014 (79 FR 10730), is extended. To ensure that your comments are considered, we must receive them by no later than May 27, 2014. ADDRESSES: You may submit comments by any one of three methods—Internet, fax, or mail. Do not submit the same comments multiple times or by more than one method. Regardless of which method you choose, please state that your comments refer to Docket No. SSA–2007–0082 so that we may associate your comments with the correct regulation. SUMMARY: Caution: You should be careful to include in your comments only information that you wish to make publicly available. We strongly urge you not to include in your comments any personal information, such as Social Security numbers or medical information. 1. Internet: We strongly recommend that you submit your comments via the Internet. Please visit the Federal eRulemaking portal at http:// www.regulations.gov. Use the Search function to find docket number SSA– 2007–0082. The system will issue you a tracking number to confirm your submission. You will not be able to view your comment immediately because we must post each comment manually. It may take up to a week for your comment to be viewable. 2. Fax: Fax comments to (410) 966– 2830. 3. Mail: Address your comments to the Office of Regulations and Reports Clearance, Social Security Administration, 107 Altmeyer Building, 6401 Security Boulevard, Baltimore, Maryland 21235–6401. Comments are available for public viewing on the Federal eRulemaking portal at http://www.regulations.gov or in person, during regular business hours, by arranging with the contact person identified below. FOR FURTHER INFORMATION CONTACT: Cheryl Williams, Office of Medical Listings Improvement, Social Security Administration, 6401 Security Boulevard, Baltimore, Maryland 21235– 6401, (410) 965–1020. For information on eligibility or filing for benefits, call our national toll-free number, 1–800– PO 00000 Frm 00015 Fmt 4702 Sfmt 9990 772–1213, or TTY 1–800–325–0778, or visit our Internet site, Social Security Online, at http:// www.socialsecurity.gov. On February 26, 2014 we published an NPRM at 79 FR 10730 that proposed to revise our medical criteria for evaluating HIV infection and functional limitations in immune system disorders. We provided the public with a 60-day comment period. The NPRM incorrectly included criteria in listing of impairment 113.00 that we did not intend to include. We are correcting that error and extending the comment period in order that the public may have a full sixty days to comment following this correction. SUPPLEMENTARY INFORMATION: Correction In proposed rule FR Doc. 2014–04124, beginning on page 10730 in the issue of Wednesday, February 26, 2014, in the proposed regulatory language section, make the following corrections: Appendix 1 to Subpart P of Part 404— [Corrected] 1. On page 10739 in the 2nd column, in Listing 113.00 of Part B of Appendix 1 to Subpart P of Part 404, remove the sentence of paragraph A. that reads, ‘‘If you have HIV infection, we use the criteria in 114.08E to evaluate carcinoma of the cervix, Kaposi sarcoma, lymphoma, and squamous cell carcinoma of the anal canal and anal margin.’’. ■ Extension of Comment Period This notice requested that the public submit comments by April 28, 2014. We are hereby extending the deadline for submitting comments to May 27, 2014. Dated: March 19, 2014. Carolyn W. Colvin, Acting Commissioner of Social Security. [FR Doc. 2014–06524 Filed 3–24–14; 8:45 am] BILLING CODE 4191–02–P E:\FR\FM\25MRP1.SGM 25MRP1

Agencies

[Federal Register Volume 79, Number 57 (Tuesday, March 25, 2014)]
[Proposed Rules]
[Page 16250]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-06524]


=======================================================================
-----------------------------------------------------------------------

SOCIAL SECURITY ADMINISTRATION

20 CFR Part 404

[Docket No. SSA-2007-0082]
RIN 0960-AG71


Revised Medical Criteria for Evaluating Human Immunodeficiency 
Virus (HIV) Infection and for Evaluating Functional Limitations in 
Immune System Disorders; Correction and Extension of Comment Period

AGENCY: Social Security Administration.

ACTION: Proposed rule; correction and extension of comment period.

-----------------------------------------------------------------------

SUMMARY: This document corrects and extends the deadline for submitting 
comments on the notice of proposed rulemaking (NPRM) published in the 
Federal Register on Wednesday, February 26, 2014, regarding Revised 
Medical Criteria for Evaluating Human Immunodeficiency Virus (HIV) 
Infection and for Evaluating Functional Limitations in Immune System 
Disorders.

DATES: The comment period for the proposed rule, published February 26, 
2014 (79 FR 10730), is extended. To ensure that your comments are 
considered, we must receive them by no later than May 27, 2014.

ADDRESSES: You may submit comments by any one of three methods--
Internet, fax, or mail. Do not submit the same comments multiple times 
or by more than one method. Regardless of which method you choose, 
please state that your comments refer to Docket No. SSA-2007-0082 so 
that we may associate your comments with the correct regulation.

    Caution:  You should be careful to include in your comments only 
information that you wish to make publicly available. We strongly 
urge you not to include in your comments any personal information, 
such as Social Security numbers or medical information.

    1. Internet: We strongly recommend that you submit your comments 
via the Internet. Please visit the Federal eRulemaking portal at http://www.regulations.gov. Use the Search function to find docket number 
SSA-2007-0082. The system will issue you a tracking number to confirm 
your submission. You will not be able to view your comment immediately 
because we must post each comment manually. It may take up to a week 
for your comment to be viewable.
    2. Fax: Fax comments to (410) 966-2830.
    3. Mail: Address your comments to the Office of Regulations and 
Reports Clearance, Social Security Administration, 107 Altmeyer 
Building, 6401 Security Boulevard, Baltimore, Maryland 21235-6401.
    Comments are available for public viewing on the Federal 
eRulemaking portal at http://www.regulations.gov or in person, during 
regular business hours, by arranging with the contact person identified 
below.

FOR FURTHER INFORMATION CONTACT: Cheryl Williams, Office of Medical 
Listings Improvement, Social Security Administration, 6401 Security 
Boulevard, Baltimore, Maryland 21235-6401, (410) 965-1020. For 
information on eligibility or filing for benefits, call our national 
toll-free number, 1-800-772-1213, or TTY 1-800-325-0778, or visit our 
Internet site, Social Security Online, at http://www.socialsecurity.gov.

SUPPLEMENTARY INFORMATION: On February 26, 2014 we published an NPRM at 
79 FR 10730 that proposed to revise our medical criteria for evaluating 
HIV infection and functional limitations in immune system disorders. We 
provided the public with a 60-day comment period. The NPRM incorrectly 
included criteria in listing of impairment 113.00 that we did not 
intend to include. We are correcting that error and extending the 
comment period in order that the public may have a full sixty days to 
comment following this correction.

Correction

    In proposed rule FR Doc. 2014-04124, beginning on page 10730 in the 
issue of Wednesday, February 26, 2014, in the proposed regulatory 
language section, make the following corrections:

Appendix 1 to Subpart P of Part 404--[Corrected]

0
1. On page 10739 in the 2nd column, in Listing 113.00 of Part B of 
Appendix 1 to Subpart P of Part 404, remove the sentence of paragraph 
A. that reads, ``If you have HIV infection, we use the criteria in 
114.08E to evaluate carcinoma of the cervix, Kaposi sarcoma, lymphoma, 
and squamous cell carcinoma of the anal canal and anal margin.''.

Extension of Comment Period

    This notice requested that the public submit comments by April 28, 
2014.
    We are hereby extending the deadline for submitting comments to May 
27, 2014.

    Dated: March 19, 2014.
Carolyn W. Colvin,
Acting Commissioner of Social Security.
[FR Doc. 2014-06524 Filed 3-24-14; 8:45 am]
BILLING CODE 4191-02-P